Schmidt PM - Search Results

1

Identification of residues crucially involved in the binding of the heme moiety of soluble guanylate cyclase.

Schmidt PM, Schramm M, Schröder H, Wunder F, Stasch JP. Schmidt PM, et al. J Biol Chem. 2004 Jan 23;279(4):3025-32. doi: 10.1074/jbc.M310141200. Epub 2003 Oct 21. J Biol Chem. 2004. PMID: 14570894 Free article.

2

Residues stabilizing the heme moiety of the nitric oxide sensor soluble guanylate cyclase.

Schmidt PM, Rothkegel C, Wunder F, Schröder H, Stasch JP. Schmidt PM, et al. Eur J Pharmacol. 2005 Apr 18;513(1-2):67-74. doi: 10.1016/j.ejphar.2005.02.046. Epub 2005 Apr 8. Eur J Pharmacol. 2005. PMID: 15878710

3

Identification of residues crucially involved in soluble guanylate cyclase activation.

Rothkegel C, Schmidt PM, Stoll F, Schröder H, Schmidt HH, Stasch JP. Rothkegel C, et al. Among authors: schmidt pm, schmidt hh. FEBS Lett. 2006 Jul 24;580(17):4205-13. doi: 10.1016/j.febslet.2006.06.079. Epub 2006 Jul 5. FEBS Lett. 2006. PMID: 16831427 Free article.

4

Dimerization region of soluble guanylate cyclase characterized by bimolecular fluorescence complementation in vivo.

Rothkegel C, Schmidt PM, Atkins DJ, Hoffmann LS, Schmidt HH, Schröder H, Stasch JP. Rothkegel C, et al. Among authors: schmidt pm, schmidt hh. Mol Pharmacol. 2007 Nov;72(5):1181-90. doi: 10.1124/mol.107.036368. Epub 2007 Aug 22. Mol Pharmacol. 2007. PMID: 17715400

5

Fluorescence dequenching makes haem-free soluble guanylate cyclase detectable in living cells.

Hoffmann LS, Schmidt PM, Keim Y, Hoffmann C, Schmidt HH, Stasch JP. Hoffmann LS, et al. Among authors: schmidt pm, schmidt hh. PLoS One. 2011;6(8):e23596. doi: 10.1371/journal.pone.0023596. Epub 2011 Aug 17. PLoS One. 2011. PMID: 21858179 Free PMC article.

6

NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle.

Stasch JP, Schmidt P, Alonso-Alija C, Apeler H, Dembowsky K, Haerter M, Heil M, Minuth T, Perzborn E, Pleiss U, Schramm M, Schroeder W, Schröder H, Stahl E, Steinke W, Wunder F. Stasch JP, et al. Br J Pharmacol. 2002 Jul;136(5):773-83. doi: 10.1038/sj.bjp.0704778. Br J Pharmacol. 2002. PMID: 12086987 Free PMC article.

7

Receptor binding assay for nitric oxide- and heme-independent activators of soluble guanylate cyclase.

Schmidt P, Schramm M, Schröder H, Stasch JP. Schmidt P, et al. Anal Biochem. 2003 Mar 1;314(1):162-5. doi: 10.1016/s0003-2697(02)00660-7. Anal Biochem. 2003. PMID: 12633618 No abstract available.

8

Mechanisms of nitric oxide independent activation of soluble guanylyl cyclase.

Schmidt P, Schramm M, Schröder H, Stasch JP. Schmidt P, et al. Eur J Pharmacol. 2003 May 16;468(3):167-74. doi: 10.1016/s0014-2999(03)01674-1. Eur J Pharmacol. 2003. PMID: 12754054

9

Preparation of heme-free soluble guanylate cyclase.

Schmidt P, Schramm M, Schröder H, Stasch JP. Schmidt P, et al. Protein Expr Purif. 2003 Sep;31(1):42-6. doi: 10.1016/s1046-5928(03)00142-6. Protein Expr Purif. 2003. PMID: 12963339

10

Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation.

Hoffmann LS, Schmidt PM, Keim Y, Schaefer S, Schmidt HH, Stasch JP. Hoffmann LS, et al. Among authors: schmidt pm, schmidt hh. Br J Pharmacol. 2009 Jul;157(5):781-95. doi: 10.1111/j.1476-5381.2009.00263.x. Epub 2009 May 18. Br J Pharmacol. 2009. PMID: 19466990 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page